Similar articles

• Comparative study of clinical outcome in kidney transplantation between early steroid withdrawal protocol using basiliximab, calcineurin inhibitor, and mycophenolate mofetil and triple regimen consisting of calcineurin inhibitor, mycophenolate mofetil, and steroid.

  Teraoka S, Sato S, Sekijima M, Iwado K, Urashima Y, Kudo S, Kai K, Koyama I, Tojinbara T, Nakajima I, Fuchinoue S. Teraoka S, et al. Transplant Proc. 2005 Mar;37(2):791-4. doi: 10.1016/j.transproceed.2004.12.185. Transplant Proc. 2005. PMID: 15848533 Clinical Trial.
• Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.

  Kato Y, Tojimbara T, Iwadoh K, Koyama I, Nanmoku K, Kai K, Sannomiya A, Nakajima I, Fuchinoue S, Teraoka S. Kato Y, et al. Int Immunopharmacol. 2006 Dec 20;6(13-14):1984-92. doi: 10.1016/j.intimp.2006.07.018. Epub 2006 Aug 10. Int Immunopharmacol. 2006. PMID: 17161352 Clinical Trial.
• Results of kidney transplantation in patients receiving MMF- or MMF and basiliximab-containing immunosuppression.

  Tojimbara T, Nakajima I, Sato S, Nakamura M, Kawase T, Kai K, Tsuda S, Kudo S, Fuchinoue S, Teraoka S. Tojimbara T, et al. Transplant Proc. 2004 Sep;36(7):2087-9. doi: 10.1016/j.transproceed.2004.08.084. Transplant Proc. 2004. PMID: 15518755
• Changing the regimen.

  Chapman JR. Chapman JR. Nephrol Dial Transplant. 1995;10 Suppl 1:51-7. doi: 10.1093/ndt/10.supp1.51. Nephrol Dial Transplant. 1995. PMID: 7617282 Review. No abstract available.
• Steroid withdrawal from cyclosporine-based regimens: con--a flawed strategy.

  Hricik DE, Schulak JA. Hricik DE, et al. Transplant Proc. 1998 Aug;30(5):1785-7. doi: 10.1016/s0041-1345(98)00431-x. Transplant Proc. 1998. PMID: 9723282 Review. No abstract available.